XML 40 R30.htm IDEA: XBRL DOCUMENT v3.25.2
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2025
Stock-Based Compensation [Abstract]  
Schedule of Weighted-Average Assumptions Used in Calculating the Fair Value of the Awards

The following table summarizes the weighted-average assumptions used in calculating the fair value of the awards for the three and six months ended June 30, 2025 and for the three months ended June 30, 2024 and the period from February 6, 2024 (inception) to June 30, 2024:

 

   Three
Months Ended
June 30,
2025
   Three
Months Ended
June 30,
2024
   Six Months Ended
June 30,
2025
   Period from February 6, 2024 (Inception) to June 30,
2024
 
Expected term (in years)   5.9    6.0    6.0    6.0 
Expected volatility   93.4%   100.6%   95.5%   101.4%
Risk-free interest rate   4.1%   4.5%   4.4%   4.4%
Expected dividend yield   
    
    
    
 
Schedule of Stock Option Activity

The following table summarizes the stock option activities under the 2024 Plan and the 2024 Stock Plan for the six months ended June 30, 2025:

 

   Number of
Stock
Options
Outstanding
   Weighted
Average
Exercise
Price
Per Share
   Weighted
Average
Remaining
Contractual
Term
(in Years)
   Aggregate
Intrinsic
Value
(in Thousands)
 
Balance as of December 31, 2024   1,567,760   $11.39    9.4   $15,470 
Granted   2,100,800   $11.97           
Exercised   
   $
           
Canceled/forfeited   
   $
           
Balance as of June 30, 2025   3,668,560   $11.72    9.3   $6,634 
Vested and expected to vest, June 30, 2025   3,668,560   $11.72    9.3   $6,634 
Exercisable, June 30, 2025   470,276   $8.04    9.0   $1,661 
Schedule of RSA Activity

The following table summarizes the RSA activity for the six months ended June 30, 2025:

 

   Number of RSAs   Weighted Average
Grant Date
Fair Value
 
Unvested balance as of December 31, 2024   2,207,553   $
 
Granted   
   $
 
Vested   (714,543)  $
 
Unvested balance as of June 30, 2025   1,493,010   $
 
Schedule of Employee Warrant Activity

The following table summarizes the employee warrant activity during the six months ended June 30, 2025:

 

   Number of
Employee
Warrants
Outstanding
   Weighted
Average
Exercise
Price
Per Share
   Weighted
Average
Remaining
Contractual
Term
(in Years)
   Aggregate
Intrinsic
Value
(in Thousands)
 
Balance as of December 31, 2024   3,054,358   $7.80    9.5   $35,400 
Granted   
   $
           
Exercised   
   $
           
Canceled/forfeited   
   $
           
Balance as of June 30, 2025   3,054,358   $7.80    9.0   $10,415 
Vested and expected to vest, June 30, 2025   3,054,358   $7.80    9.0   $10,415 
Exercisable, June 30, 2025   797,307   $7.80    9.0   $2,719 
Schedule of Company’s Stock-Based Compensation Expense

The following table summarizes the classification of the Company’s stock-based compensation expense in the condensed consolidated statements of operations and comprehensive loss (in thousands):

 

  

Three
Months Ended

June 30,
2025

  

Three
Months Ended

June 30,
2024

   Six Months Ended
June 30,
2025
   Period from
February 6,
2024
(Inception) to
June 30,
2024
 
Research and development  $3,368   $468   $6,371   $538 
General and administrative   1,709    215    3,589    230 
Total  $5,077   $683   $9,960   $768 
Schedule of Award Types of Company’s Stock-Based Compensation Expense

The following table summarizes the award types of the Company’s stock-based compensation expense in the condensed consolidated statements of operations and comprehensive loss (in thousands): 

 

  

Three
Months Ended

June 30,
2025

  

Three
Months Ended

June 30,
2024

   Six Months Ended
June 30,
2025
   Period from
February 6,
2024
(Inception) to
June 30,
2024
 
Paruka Warrant Obligation  $1,674   $362   $3,089   $430 
Employee warrants   1,238    
    2,789    
 
Stock options   2,130    321    4,019    338 
Employee stock purchase plan   35    
    63    
 
Total  $5,077   $683   $9,960   $768